Site icon news.soban.in

Mankind Pharma Q4 PAT rises 30% on strong domestic biz, chronic push(Soban News)

Mankind Pharma posted a 30.4% rise in Q4FY26 profit, driven by strong demand for chronic therapies and OTC healthcare products

​Mankind Pharma posted a 30.4% rise in Q4FY26 profit, driven by strong demand for chronic therapies and OTC healthcare products by Soban News (international And National News)

Exit mobile version